This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?-a SEER database analysis. J Gastrointest Surg 2013; Epub 2013/11/16. 10.1007/s11605-013-2345-8DubeczASolymosiNStadlhuberRJSchweigertMSteinHJPetersJH.Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?-a SEER database analysis10.1007/s11605-013-2345-824234242Open DOISearch in Google Scholar
Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-6. 10.1093/jnci/dji02415657344PohlHWelchHG.The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence200597142610.1093/jnci/dji02415657344Open DOISearch in Google Scholar
Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 2008; 23: 1662-5. 10.1111/j.1440-1746.2008.05572.xKusanoCGotodaTKhorCJKataiHKatoHTaniguchiHChanging trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan2008231662510.1111/j.1440-1746.2008.05572.x19120859Open DOISearch in Google Scholar
Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol 2002; 14: 107-13.10.1097/00042737-200202000-0000311981333BlaserMJSaitoD.Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan2002141071311981333Open DOISearch in Google Scholar
Yamashita K, Sakuramoto S, Nemoto M, Shibata T, Mieno H, Katada N, et al. Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol 2011; 17: 3390-7. 10.3748/wjg.v17.i29.339021876631YamashitaKSakuramotoSNemotoMShibataTMienoHKatadaNTrend in gastric cancer: 35 years of surgical experience in Japan2011173390710.3748/wjg.v17.i29.3390316056521876631Open DOISearch in Google Scholar
Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002; 89: 1156-63. 10.1046/j.1365-2168.2002.02185.x12190682MarietteCCastelBTourselHFabreSBalonJMTribouletJP.Surgical management of and long-term survival after adenocarcinoma of the cardia20028911566310.1046/j.1365-2168.2002.02185.x12190682Open DOISearch in Google Scholar
Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R. Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. Surg Oncol 2014; 23: 222-8. 10.1016/j.suronc.2014.10.00425466852HaverkampLRuurdaJPvan LeeuwenMSSiersemaPDvan Hillegersberg R. Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction201423222810.1016/j.suronc.2014.10.00425466852Open DOISearch in Google Scholar
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9. 10.1046/j.1365-2168.1998.00940.x9823902SiewertJRSteinHJ.Classification of adenocarcinoma of the oesophagogastric junction1998851457910.1046/j.1365-2168.1998.00940.x9823902Open DOISearch in Google Scholar
Kauppila JH, Lagergren J. The surgical management of esophago-gastric junctional cancer. Surg Oncol 2016; 25: 394-400. 10.1016/j.suronc.2016.09.00427916171KauppilaJHLagergrenJ.The surgical management of esophago-gastric junctional cancer20162539440010.1016/j.suronc.2016.09.00427916171Open DOISearch in Google Scholar
Kulig P, Sierzega M, Pach R, Kolodziejczyk P, Kulig J, Group PGCS. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location. Eur J Surg Oncol 2016; 42: 1215-21. 10.1016/j.ejso.2016.04.061KuligPSierzegaMPachRKolodziejczykPKuligJGroup PGCS. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location20164212152110.1016/j.ejso.2016.04.06127241921Open DOISearch in Google Scholar
Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 2013; 100: 1050-4. 10.1002/bjs.917023754647MineSSanoTHikiNYamadaKKosugaTNunobeSProximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction20131001050410.1002/bjs.9170Open DOISearch in Google Scholar
Wei MT, Zhang YC, Deng XB, Yang TH, He YZ, Wang ZQ. Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis. World J Gastroenterol 2014; 20: 10183-92. 10.3748/wjg.v20.i29.1018325110447WeiMTZhangYCDengXBYangTHHeYZWangZQ.Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis201420101839210.3748/wjg.v20.i29.10183Open DOISearch in Google Scholar
Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, et al. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 2017. Epub 2017/07/06. 10.1007/s10120-017-0746-1BlankSSchmidtTHegerPStrowitzkiMJSisicLHegerUSurgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 201710.1007/s10120-017-0746-1Open DOISearch in Google Scholar
Uzunoglu FG, Reeh M, Kutup A, Izbicki JR. Surgery of esophageal cancer. Langenbecks Arch Surg 2013; 398: 189-93. 10.1007/s00423-013-1052-y23354360UzunogluFGReehMKutupAIzbickiJR.Surgery of esophageal cancer20133981899310.1007/s00423-013-1052-yOpen DOISearch in Google Scholar
Al-Haddad S, Chang AC, De Hertogh G, Grin A, Langer R, Sagaert X, et al. Adenocarcinoma at the gastroesophageal junction. Ann N Y Acad Sci 2014; 1325: 211-25. 10.1111/nyas.1253525266027Al-HaddadSChangACDe HertoghGGrinALangerRSagaertXAdenocarcinoma at the gastroesophageal junction201413252112510.1111/nyas.12535Open DOISearch in Google Scholar
Di Leo A, Zanoni A. Siewert III adenocarcinoma: treatment update. Updates Surg 2017. Epub 2017/03/16. 10.1007/s13304-017-0429-9Di LeoAZanoniA.Siewert III adenocarcinoma: treatment update10.1007/s13304-017-0429-9Open DOISearch in Google Scholar
Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer 2017; 20(Suppl 1): 69-83. 10.1007/s10120-016-0663-827796514YamashitaHSetoYSanoTMakuuchiHAndoNSasakoM.Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma2017201698310.1007/s10120-016-0663-8Open DOISearch in Google Scholar
Kleinberg L, Brock M, Gibson M. Management of locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: Finally a consensus. Curr Treat Options Oncol 2015; 16: 35. 10.1007/s11864-015-0352-626112428KleinbergLBrockMGibsonM.Management of locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: Finally a consensus2015163510.1007/s11864-015-0352-6Open DOISearch in Google Scholar
Cohen DJ, Leichman L. Controversies in the treatment of local and locally advanced gastric and esophageal cancers. J Clin Oncol 2015; 33: 1754-9. 10.1200/jco.2014.59.776525918302CohenDJLeichmanL.Controversies in the treatment of local and locally advanced gastric and esophageal cancers2015331754910.1200/jco.2014.59.7765Open DOISearch in Google Scholar
Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998; 82: 621-31.10.1002/(SICI)1097-0142(19980215)82:4<621::AID-CNCR2>3.0.CO;2-ORoderJDBottcherKBuschRWittekindCHermanekPSiewertJR.Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group19988262131Open DOISearch in Google Scholar
Doyle DJ, Garmon E. American Society of Anesthesiologists Classification (ASA Class). StatPearls. Treasure Island (FL): StatPearls PublishingStatPearls Publishing LLC.; 2017.DoyleDJGarmonE.American Society of Anesthesiologists Classification (ASA Class)Treasure Island (FL)StatPearls PublishingStatPearls Publishing LLC.2017Search in Google Scholar
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24. 10.1007/s101209800016Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma219981102410.1007/s10120980001611957040Open DOISearch in Google Scholar
Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, et al. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer 2013; 16: 590-5. 10.1007/s10120-012-0214-x23179369GotoHTokunagaMSugisawaNTanizawaYBandoEKawamuraTValue of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction201316590510.1007/s10120-012-0214-x23179369Open DOISearch in Google Scholar
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt to a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.LaurenP.The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma196564314910.1111/apm.1965.64.1.3114320675Search in Google Scholar
TNM classification of malignant tumours. Eighth edition. Brierley J, Gospodarowicz MK, Wittekind C, editors. Chichester, West Sussex: John Wiley & Sons, Inc; 2017.EighthBrierleyJGospodarowiczMKWittekindCeditorsChichester, West SussexJohn Wiley & Sons, Inc2017Search in Google Scholar
Wittekind C. [Patology of gastric carcinoma: typing, grading and staging]. [German]. Chir Gastroenterol 1999; 15: 216-22. 10.1159/000012560.WittekindC.[Patology of gastric carcinoma: typing, grading and staging]1999152162210.1159/000012560Open DOISearch in Google Scholar
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13. org/10.1097/01.sla.0000133083.54934.ae.DindoDDemartinesNClavienPA.Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey200424020513org/10.1097/01.sla.0000133083.54934.aeOpen DOISearch in Google Scholar
Fox MP, van Berkel V. Management of gastroesophageal junction tumors. Surg Clin North Am 2012; 92: 1199-212. 10.1016/j.suc.2012.07.01123026278FoxMPvan BerkelV.Management of gastroesophageal junction tumors201292119921210.1016/j.suc.2012.07.01123026278Open DOISearch in Google Scholar
Mullen JT, Kwak EL, Hong TS. What’s the best way to treat GE junction tumors? Approach like gastric cancer. Ann Surg Oncol 2016; 23: 3780-5. 10.1245/s10434-016-5426-627459983MullenJTKwakELHongTS.What’s the best way to treat GE junction tumors? Approach like gastric cancer2016233780510.1245/s10434-016-5426-627459983Open DOISearch in Google Scholar
Rizk N. Gastroesophageal junction tumors. Ann Surg Oncol 2016; 23: 3798-800. 10.1245/s10434-016-5427-527491783RizkN.Gastroesophageal junction tumors201623379880010.1245/s10434-016-5427-527491783Open DOISearch in Google Scholar
Giacopuzzi S, Bencivenga M, Weindelmayer J, Verlato G, de Manzoni G. Western strategy for EGJ carcinoma. Gastric Cancer 2017; 20(Suppl 1): 60-8. 10.1007/s10120-016-0685-228039533GiacopuzziSBencivengaMWeindelmayerJVerlatoGde ManzoniG.Western strategy for EGJ carcinoma201720160810.1007/s10120-016-0685-228039533Open DOISearch in Google Scholar
Duan F, Cui S, Song C, Zhao X, Dai L, Shen Y. Esophageal squamous cell carcinoma and gastric cardia adenocarcinoma shared susceptibility locus in C20orf54: Evidence from published studies. Sci Rep 2015; 5: 11961. 10.1038/srep1196126154995DuanFCuiSSongCZhaoXDaiLShenY.Esophageal squamous cell carcinoma and gastric cardia adenocarcinoma shared susceptibility locus in C20orf54: Evidence from published studies201551196110.1038/srep11961449561626154995Open DOISearch in Google Scholar
Hosoda K, Yamashita K, Moriya H, Mieno H, Watanabe M. Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: a retrospective cohort study with long-term follow-up. World J Gastroenterol 2017; 23: 2723-30. 10.3748/wjg.v23.i15.272328487609HosodaKYamashitaKMoriyaHMienoHWatanabeM.Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: a retrospective cohort study with long-term follow-up20172327233010.3748/wjg.v23.i15.2723540375128487609Open DOISearch in Google Scholar
Lee IS, Ahn JY, Yook JH, Kim BS. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol 2017; 15: 28. 10.1186/s12957-016-1088-x28100248LeeISAhnJYYookJHKimBS.Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma2017152810.1186/s12957-016-1088-x524209128100248Open DOISearch in Google Scholar
Lochowski M, Lochowska B, Kozak J. Transthoracic versus transhiatal esophagectomy - influence on patient survival. Prz Gastroenterol 2017; 12: 118-21. 10.5114/pg.2016.6460928702100LochowskiMLochowskaBKozakJ.Transthoracic versus transhiatal esophagectomy - influence on patient survival2017121182110.5114/pg.2016.64609549712628702100Open DOISearch in Google Scholar
Fontana MG, La Pinta M, Moneghini D, Villanacci V, Donato F, Rindi G, et al. Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer 2003; 88: 401-5. 10.1038/sj.bjc.660066312569383FontanaMGLa PintaMMoneghiniDVillanacciVDonatoFRindiGPrognostic value of Goseki histological classification in adenocarcinoma of the cardia200388401510.1038/sj.bjc.6600663274754312569383Open DOISearch in Google Scholar
Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, Nashimoto A, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br JSurg 2015; 102: 341-8. 10.1002/bjs.976425605628KurokawaYSasakoMSanoTYoshikawaTIwasakiYNashimotoATen-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia2015102341810.1002/bjs.9764502402225605628Open DOISearch in Google Scholar
Mine S, Watanabe M. A commentary on “Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia”. Transl Gastroenterol Hepatol 2016; 1: 12. 10.21037/tgh.2016.03.08MineSWatanabeM.A commentary on “Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia”201611210.21037/tgh.2016.03.08524459928138579Open DOISearch in Google Scholar
Kim KT, Jeong O, Jung MR, Ryu SY, Park YK. Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: Single center’s experience in Korea. J Gastric Cancer 2012; 12: 36-42. 10.5230/jgc.2012.12.1.3622500262KimKTJeongOJungMRRyuSYParkYK.Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: Single center’s experience in Korea201212364210.5230/jgc.2012.12.1.36331979822500262Open DOISearch in Google Scholar